Cargando…
Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature
BACKGROUND: Gastrointestinal perforation is known as a serious adverse event, but, for breast cancer, there are very few reports of gastrointestinal perforation. This report highlights gastrointestinal perforation caused by bevacizumab for breast cancer, which is of special interest because gastroin...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870367/ https://www.ncbi.nlm.nih.gov/pubmed/29580267 http://dx.doi.org/10.1186/s13256-018-1619-x |